Spain's oncology clinical trials market is projected to grow from $244.1 Mn in 2022 to $347.2 Mn by 2030, registering a CAGR of 4.5% during the forecast period of 2022-30. The market will be driven by the rising frequency of cancer in the population and the country's well-developed clinical research infrastructure. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, FHoffmann-La Roche Ltd & Grifols.
Spain's oncology clinical trials market is projected to grow from $244.1 Mn in 2022 to $347.2 Mn by 2030, registering a CAGR of 4.5% during the forecast period of 2022-30. With a population of almost 47 million people, Spain is the fourth-largest nation in the European Union. Yet, Spain is regarded foremost not just because of its size, but also because of its unique expertise in conducting Clinical Trials in a variety of therapeutic sectors. Spain accounted for 4.1% of worldwide Clinical Trials activity in 2021. Moreover, Spain dramatically expanded the participant base in the last year, reaching roughly 145 000 Patients in over 3 400 Clinical Studies. More than 276 thousand new instances of cancer were projected to be identified in Spain in 2021, with 159 thousand in males and 117 thousand in women. With more than 43 thousand new cases in 2021, bowel cancer, commonly known as colon cancer, is the kind with the greatest incidence in the nation, followed by prostate and breast cancer with 35.8 and 33.4 thousand, respectively.
Oncology clinical trials in Spain are an essential aspect of the country's healthcare system since they enable the development of novel cancer treatments and cures. Many research organizations and hospitals in Spain such as Vall d'Hebron Institute of Oncology, Hospital Universitario 12 de Octubre, Hospital Universitario Virgen del Rocio, Hospital Clinic Barcelona & Catalan Institute of Oncology are actively participating in cancer clinical trials, and the nation has a well-developed regulatory framework in place to assure patient safety and ethical trial conduct. Immunotherapy research for several forms of cancer, such as melanoma, lung cancer, and breast cancer, is among the active oncology clinical trials in Spain. There are additional studies focusing on targeted medicines for certain cancers, such as ovarian and pancreatic cancer.
In July 2022, Labcorp (a leading global life sciences company) entered into a collaboration with the MD Anderson Cancer Center Foundation Spain in order to improve access to early-phase oncology clinical trials.
Market Growth Drivers
Many reasons are driving the expansion of cancer clinical trials in Spain. One of the key factors is the country's well-developed clinical research infrastructure. Spain has a substantial and well-trained healthcare staff, as well as a robust network of hospitals and research facilities capable of conducting clinical trials. Moreover, the Spanish government has been supportive of clinical research and has adopted rules and regulations to encourage the discovery of novel cancer cures and therapies.
The rising frequency of cancer in the population is another reason driving the expansion of oncology clinical trials in Spain. Cancer rates in Spain, like many other nations, have risen in recent years, increasing the need for novel and more effective therapies. Clinical trials are required for the development of these therapies, and as a result, the number of studies being undertaken in the nation has increased.
There are also various constraints impeding the expansion of cancer clinical trials in Spain. One of the major constraints is the scarcity of finance for clinical research. Clinical trials may be costly to carry out, and many hospitals and research facilities in Spain have inadequate resources to support this work. Moreover, the nation has a scarcity of trained clinical research specialists, making it challenging to attract and retain employees for clinical studies. Another impediment to the expansion of cancer clinical trials in Spain is the regulatory environment's complexity. Although the Spanish government has enacted laws and regulations to support clinical research, hospitals, and research institutes, especially those that are new to conducting clinical trials, may find it difficult to navigate these rules.
1. Report Description of the Spain Oncology Clinical Trials Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Spain Oncology Clinical Trials Market Executive Summary
2.1 Spain Oncology Clinical Trials Market - Industry Snapshot & key buying criteria, 2022-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Spain Oncology Clinical Trials Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Spain Oncology Clinical Trials Market Segmentation
4.1 By Phase
4.1.1 Phase I
4.1.2 Phase II
4.1.3 Phase III
4.1.4 Phase IV
4.2 By Cancer Type
4.2.1 Lung cancer
4.2.2 Breast cancer
4.2.3 Thyroid cancer
4.2.5 Liver cancer
4.2.6 Skin cancer
4.2.8 Pancreatic cancer
4.2.9 Prostate cancer
4.2.10 Colon & rectal cancer
4.2.11 Urinary system cancer
4.2.12 Other cancer
4.3 By Indication Outlook
4.3.3 Expanded Access
5. Spain Oncology Clinical Trials Market Share
5.1 Market Analysis, Insights, and Forecast - By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Spain
8.2 Regulatory Framework in Spain
8.3 Pricing & Reimbursement Scenario in Spain Oncology Clinical Trials Market
9. Factors Driving Future Growth
9.1 New Trends and Development Spain Oncology Clinical Trials Market
9.2 Future Opportunities
10. Strategic Recommendations
By Phase (Revenue, USD Billion):
By Study Design Outlook (Revenue, USD Billion):
By Indication Outlook (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses